Immuno-oncology Market Size, Share, Trends, Analysis and Forecast by Region, Segment, Type (Checkpoint Modulators, Cancer Vaccines) and End-User (Hospitals, Cancer Research Institute), 2022-2030
LONDON, UK, October 24, 2022 /EINPresswire.com/ — The world immuno-oncology market was price almost $45,121.62 million in 2021. The immuno-oncology market is anticipated to develop at a greater than CAGR of 20% over the subsequent 10 years. Major components resembling a rise in healthcare expenditure, an increase within the prevalence and incidence of most cancers, a surge in technological development in most cancers therapy, and novel product launches are anticipated to enhance market progress through the forecast interval.
View Report Outlook at: https://www.globaldata.com/store/report/immuno-oncology-market-trend-analysis/
The immuno-oncology market report provided by GlobalData Plc offers an outline of the immuno-oncology market dimension & forecast by class, end-user, and geography. It additionally helps us perceive the immuno-oncology worth chain and determine the important thing distributors available in the market.
Learn concerning the Immuno-oncology Market Dynamics by Viewing Report Sample Right Here!
Immuno-oncology Market Report Highlights
• The world immuno-oncology market is projected to witness a CAGR of 20.30% from 2021 to 2030, reaching a price of $238.19 billion. Major components resembling a rise in healthcare expenditure, an increase in prevalence and incidence of most cancers, a surge in technological development in most cancers therapy, and novel product launches are anticipated to enhance the market progress through the forecast interval
• In 2021, the checkpoint modulators phase of the immuno-oncology market is estimated at US$36.45 billion in 2021 and is forecast to reach US$191.38 billion by 2030, rising at a CAGR of 20.23%.
• The hospitals phase of the immuno-oncology market is estimated at $37.22 billion in 2021 and is anticipated to develop up to $195.64 billion by 2030, rising at a CAGR of 20.25%.
• North America intently adopted by Europe captured over 60% of the general immuno-oncology share in 2021. The rise in most cancers incidence, approval of novel drug therapies, rising funding and funding for the event of immuno-oncology medication, and a rise in strategic partnerships are the foremost components contributing to the market progress.
• The immuno-oncology market key gamers analyzed as a part of this report are Amgen, AstraZeneca, Roche, amongst others
Unlock extra market dynamics impacting the immuno-oncology market progress by Requesting a Sample PDF
GlobalData Plc has segmented the immuno-oncology market report by class, End-user, and area:
Global immuno-oncology class Outlook (Revenue, USD Million, 2022-2030)
• Checkpoint Modulators
• Cancer vaccines
• Cell Therapies
• Bispecific antibodies
• Cytokines
• Oncolytic Viruses
Global immuno-oncology end-user Outlook (Revenue, USD Million, 2022-2030)
• Hospitals
• Cancer Research Centers
• Others
Immuno-oncology market outlook report with detailed phase evaluation is accessible with Global Data Now! Make a Purchase Right Here!
Global Immuno-oncology Regional Outlook (Revenue, USD Million, 2022-2030)
• North America
• US
• Canada
• Mexico
• Europe
• UK
• Germany
• France
• Italy
• Spain
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• South Korea
• Australia
• Rest of Asia Pacific
• ROW
• UAE
• Saudi Arabia
• Brazil
• Rest of ROW
About us
GlobalData is a number one supplier of information, analytics, and insights on the world’s largest industries. In an more and more fast-moving, advanced, and unsure world, it has by no means been tougher for organizations and decision-makers to predict and navigate the long run. GlobalData’s mission is to assist our purchasers to decode the long run and revenue from sooner, extra knowledgeable selections. As a number one data companies firm, hundreds of purchasers depend on us for trusted, well timed, and actionable intelligence. Our options are designed to present a each day edge to professionals inside companies, monetary establishments, skilled companies, and authorities businesses.
Media Contacts
Mark Jephcott
GlobalData Plc
+44 20 7936 6400
[email protected]
Visit us on social media:
Twitter
LinkedIn
